Cooperman Barnabas Medical Center is a clinical research site located in Livingston, New Jersey, United States 07039.
Crixeo Clinical Trials Trust Score: 28/100 (FAILING). This profile has not yet been claimed by the site owner.
Cooperman Barnabas Medical Center has participated in 59 clinical trials with 52 currently active.
Therapeutic areas: Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.
Sponsors: National Cancer Institute (NCI), Rutgers, The State University of New Jersey, Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New Jersey · View every site in Livingston
Trust Score: 28/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Cooperman Barnabas Medical Center has a Crixeo Trust Score of 28/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cooperman Barnabas Medical Center has 59 clinical trials on record, with 52 currently active. Their work covers Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8.
Cooperman Barnabas Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.